Most recently, it's been determined that conolidine and the above derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in equivalent parts as classical opioid receptors, it binds to some wide array of endogenous opioids. Not like most opioid receptors, this receptor acts as a scavenger and isn't going to activate a next messenge… Read More